313 related articles for article (PubMed ID: 37383389)
21. Novel immune-related gene signature for risk stratification and prognosis prediction in ovarian cancer.
Fei H; Han X; Wang Y; Li S
J Ovarian Res; 2023 Oct; 16(1):205. PubMed ID: 37858138
[TBL] [Abstract][Full Text] [Related]
22. A novel anoikis-related prognostic signature associated with prognosis and immune infiltration landscape in clear cell renal cell carcinoma.
Chen Z; Liu X; Zhu Z; Chen J; Wang C; Chen X; Zhu S; Zhang A
Front Genet; 2022; 13():1039465. PubMed ID: 36338978
[No Abstract] [Full Text] [Related]
23. Identification of a new anoikis-related gene signature for prognostic significance in head and neck squamous carcinomas.
Wei Z; Zhou C; Shen Y; Deng H; Shen Z
Medicine (Baltimore); 2023 Sep; 102(36):e34790. PubMed ID: 37682196
[TBL] [Abstract][Full Text] [Related]
24. Development and verification of a 7-lncRNA prognostic model based on tumor immunity for patients with ovarian cancer.
Feng J; Yu Y; Yin W; Qian S
J Ovarian Res; 2023 Feb; 16(1):31. PubMed ID: 36739404
[TBL] [Abstract][Full Text] [Related]
25. Prognostic analyses of genes associated with anoikis in breast cancer.
Cao J; Ma X; Zhang G; Hong S; Ma R; Wang Y; Yan X; Ma M
PeerJ; 2023; 11():e15475. PubMed ID: 37842046
[TBL] [Abstract][Full Text] [Related]
26. Identification of a novel anoikis-related gene signature to predict prognosis and tumor microenvironment in lung adenocarcinoma.
Diao X; Guo C; Li S
Thorac Cancer; 2023 Jan; 14(3):320-330. PubMed ID: 36507553
[TBL] [Abstract][Full Text] [Related]
27. An anoikis-based gene signature for predicting prognosis in malignant pleural mesothelioma and revealing immune infiltration.
Shi J; Peng B; Zhou X; Wang C; Xu R; Lu T; Chang X; Shen Z; Wang K; Xu C; Zhang L
J Cancer Res Clin Oncol; 2023 Oct; 149(13):12089-12102. PubMed ID: 37421452
[TBL] [Abstract][Full Text] [Related]
28. Glycosylation-related genes mediated prognostic signature contribute to prognostic prediction and treatment options in ovarian cancer: based on bulk and single‑cell RNA sequencing data.
You Y; Yang Q
BMC Cancer; 2024 Feb; 24(1):207. PubMed ID: 38355446
[TBL] [Abstract][Full Text] [Related]
29. Identification of an Autophagy-Related Signature for Prognosis and Immunotherapy Response Prediction in Ovarian Cancer.
Ding J; Wang C; Sun Y; Guo J; Liu S; Cheng Z
Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830707
[TBL] [Abstract][Full Text] [Related]
30. The novel transcriptomic signature of angiogenesis predicts clinical outcome, tumor microenvironment and treatment response for prostate adenocarcinoma.
Gu CY; Dai B; Zhu Y; Lin GW; Wang HK; Ye DW; Qin XJ
Mol Med; 2022 Jul; 28(1):78. PubMed ID: 35836112
[TBL] [Abstract][Full Text] [Related]
31. Anoikis-related genes signature development for clear cell renal cell carcinoma prognosis and tumor microenvironment.
Jiang Y; Wang Y; Wang Z; Zhang Y; Hou Y; Wang X
Sci Rep; 2023 Nov; 13(1):18909. PubMed ID: 37919386
[TBL] [Abstract][Full Text] [Related]
32. Establishment of an ovarian cancer omentum metastasis-related prognostic model by integrated analysis of scRNA-seq and bulk RNA-seq.
Zhang D; Lu W; Cui S; Mei H; Wu X; Zhuo Z
J Ovarian Res; 2022 Nov; 15(1):123. PubMed ID: 36424614
[TBL] [Abstract][Full Text] [Related]
33. Identification of A novel anoikis-related genes-based signature for non-small cell lung cancer.
Lei J; Guo G; Liang D; Gong L; Zhang L; Wang X
Biochem Biophys Res Commun; 2023 Sep; 673():137-144. PubMed ID: 37385008
[TBL] [Abstract][Full Text] [Related]
34. Development of a prognostic signature based on anoikis-related genes in hepatocellular carcinoma with the utilization of LASSO-cox method.
Yu Z; Shi FE; Mao Y; Song A; He L; Gao M; Wei H; Xiao F; Wei H
Medicine (Baltimore); 2023 Jul; 102(29):e34367. PubMed ID: 37478222
[TBL] [Abstract][Full Text] [Related]
35. Association between tumor mutation burden and immune infiltration in ovarian cancer.
Fan S; Gao X; Qin Q; Li H; Yuan Z; Zhao S
Int Immunopharmacol; 2020 Dec; 89(Pt A):107126. PubMed ID: 33189611
[TBL] [Abstract][Full Text] [Related]
36. Integrative analysis of cuproptosis-associated genes for predicting immunotherapy response in single-cell and multi-cohort studies.
Li H; Wang Y; Li G; Xiong J; Qin L; Wen Q; Yue C
J Gene Med; 2024 Jan; 26(1):e3600. PubMed ID: 37776237
[TBL] [Abstract][Full Text] [Related]
37. Establishment and validation of an aging-related risk signature associated with prognosis and tumor immune microenvironment in breast cancer.
Wang Z; Liu H; Gong Y; Cheng Y
Eur J Med Res; 2022 Dec; 27(1):317. PubMed ID: 36581948
[TBL] [Abstract][Full Text] [Related]
38. A nine-gene signature related to tumor microenvironment predicts overall survival with ovarian cancer.
Ding Q; Dong S; Wang R; Zhang K; Wang H; Zhou X; Wang J; Wong K; Long Y; Zhu S; Wang W; Ren H; Zeng Y
Aging (Albany NY); 2020 Mar; 12(6):4879-4895. PubMed ID: 32208363
[TBL] [Abstract][Full Text] [Related]
39. Derivation and Comprehensive Analysis of Aging Patterns in Patients with Bladder Cancer.
Wang B; Tong F; Zhai C; Wang L; Liu Y; Wang J
Dis Markers; 2021; 2021():3385058. PubMed ID: 34721733
[TBL] [Abstract][Full Text] [Related]
40. A novel anoikis-related prognostic signature associated with prognosis and immune infiltration landscape in lung adenocarcinoma.
Liu Y; Hu S; Teng M; Qing Y; Dong X; Chen L; Ai K
J Gene Med; 2024 Feb; 26(1):e3610. PubMed ID: 37985130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
